HIV
Main content start
Site content
- Rönn, M., Kourtis, A., Liang, Y., Zheng, L., Puente, T., Huang, Y., Zhu, W., Patel, R., Weiner, J., Hoover, K., Van Handel, M., Menzies, N., & Salomon, J. (2026). Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: A comparison of behavioral, acquisition-risk based, and economic metrics. Annals of Epidemiology, 118, 11079. https://doi.org/10.1016/j.annepidem.2026.110079
- Bellerose, M., Zhu, L., Hagan, L., Thompson, W., Randall, L., Malyuta, Y., Salomon, J., & Linas, B. (2021). A review of network simulation models of hepatitis C virus and HIV among people who inject drugs. International Journal of Drug Policy, 88. https://doi.org/10.1016/j.drugpo.2019.10.006
- Neilan, A., Dunville, R., Ocfemia, M., Salomon, J., Francke, J., Wang, L., Bulteel, A., Hsu, K., DiNenno, E., Parker, R., & Walensky, R. (2017). Screening adolescents and young adults for HIV in the United States: A cost-effectiveness analysis. Journal of Adolescent Health, 60(2), S18. https://doi.org/10.1016/j.jadohealth.2016.10.055